MarkBernardEffronMD

PubMed

• 4 citations
  Proposal for a Simple Algorithmic Approach to Manage Drug-Drug Interactions of Oral Anticoagulants with Nirmatrelvir/Ritonavir in COVID-19 Outpatients.
  John G Rizk, Jose G Lazo Jr, Aashish Gupta, Carl J Lavie, Mark B Effron> ;Seminars in Thrombosis and Hemostasis. 2023 Feb 1
• 109 citations
  Comparative effectiveness of aspirin dosing in cardiovascular disease.
  W. Schuyler Jones, Hillary Mulder, Lisa M. Wruck, Michael J. Pencina, Sunil Kripalani, Daniel Muñoz, David L. Crenshaw, Mark B. Effron, Richard N. Re, Kamal Gupta, R. ...> ;The New England Journal of Medicine. 2021 May 15
• 3 citations
  Clinician engagement in the ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) trial.
  Ajar Kochar, Mary B Summers, Catherine P. Benziger, Guillaume Marquis-Gravel, Darren A. DeWalt, Carl J. Pepine, Kamal Gupta, Steven M. Bradley, John A. Dodson, Brent C...> ;Clinical Trials. 2021 Feb 4
• 4 citations
  Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention- Results from the PRO...
  Rishi Chandiramani, Huazhen Chen, Shunsuke Aoi, Gennaro Giustino, Bimmer E. Claessen, Samantha Sartori, Melissa Aquino, Sabato Sorrentino, Davide Cao, Ridhima Goel, An...> ;Catheterization and Cardiovascular Interventions. 2020 Apr 1
• 52 citations
  Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial.
  Guillaume Marquis-Gravel, Matthew T. Roe, Holly Robertson, Robert A. Harrington, Michael J. Pencina, Lisa G. Berdan, Bradley G. Hammill, Madelaine Faulkner, Daniel Muñ...> ;JAMA Cardiology. 2020 May 1
• 5 citations
  Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study.
  Jaya Chandrasekhar, Usman Baber, Samantha Sartori, Melissa Aquino, Kamilia Moalem, Annapoorna Kini, Sunil V. Rao, William S. Weintraub, Timothy D. Henry, Birgit Vogel,...> ;Clinical Research in Cardiology. 2020 Jan 8
• 4 citations
  Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome: an analysis from the PROMETHEUS registry.
  Zhen Ge, Usman Baber, Bimmer E. Claessen, Jaya Chandrasekhar, Rishi Chandiramani, Shawn X. Li, Samantha Sartori, Annapoorna Kini, Sunil V. Rao, Sandra Weiss, Timothy D...> ;Journal of Thrombosis and Thrombolysis. 2019 Mar 28
• 10 citations
  The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETH...
  Zhen Ge, Usman Baber, Bimmer E. Claessen, Serdar Farhan, Jaya Chandrasekhar, Shawn X. Li, Samantha Sartori, Annapoorna Kini, Sunil V. Rao, Sandra Weiss, Timothy Henry,...> ;Catheterization and Cardiovascular Interventions. 2019 Feb 15
• Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes.
  Faggioni, M.,Baber, U.,Chandrasekhar, J.,Sartori, S.,Weintraub, W.,Rao, S. V.,Vogel, B.,Claessen, B.,Kini, A.,Effron, M.,Ge, Z.,Keller, S.,Strauss, C.,Snyder, C.,Toma,...> ;Catheter Cardiovasc Interv. 2019 Jan 19
• 9 citations
  Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary in...
  Michela Faggioni, Usman Baber, Jaya Chandrasekhar, Samantha Sartori, Bimmer E. Claessen, Sunil V. Rao, Birgit Vogel, Mark B. Effron, Kanhaiya L. Poddar, Serdar Farhan,...> ;International Journal of Cardiology. 2019 Jan 15
• 7 citations
  Glycoprotein IIb/IIIa inhibitor use in patients with acute myocardial infarction undergoing PCI: Insights from the TRANSLATE ACS study.
  Homam Ibrahim, Lisa A. Kaltenbach, Connie N. Hess, Tammy Recchia, Mark B. Effron, Gregg W. Stone, Tracy Y. Wang> ;Catheterization and Cardiovascular Interventions. 2019 Mar 1
• 4 citations
  One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims Database
  Mark B. Effron, Kavita V. Nair, Cliff Molife, Stuart Keller, Robert L. Page, Jason C. Simeone, Brian R. Murphy, Beth L. Nordstrom, Yajun Zhu, Patrick L. McCollam, Geor...> ;American Journal of Cardiovascular Drugs. 2018 Apr 1
• 17 citations
  Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study
  Jaya Chandrasekhar, Usman Baber, Samantha Sartori, Melissa Aquino, Annapoorna Kini, Sunil V. Rao, William S. Weintraub, Timothy D. Henry, Serdar Farhan, Birgit Vogel, ...> ;The Canadian Journal of Cardiology. 2017 Dec 27
• 3 citations
  Antiplatelet Therapy Changes for Patients With Myocardial Infarction With Recurrent Ischemic Events: Insights Into Contemporary Practice From the TRANSLATE‐ACS (Treatm...
  Alexander C. Fanaroff, Lisa A. Kaltenbach, Eric D. Peterson, Mohammed Akhter, Mark B. Effron, Timothy D. Henry, Tracy Y. Wang> ;Journal of the American Heart Association. 2018 Feb 8
• 4 citations
  The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary int...
  Mark B. Effron, Tracy Y. Wang, Gregg C. Fonarow, Timothy D. Henry, Marjorie Zettler, Brian A. Baker, Lisa A. McCoy, Eric D. Peterson> ;Catheterization and Cardiovascular Interventions. 2018 Feb 1
• The Waxing and Waning of Antithrombotic Therapy in Cardiovascular Disease - Where Is the Moon Now?
  Mark B. Effron, C. Michael Gibson> ;Progress in Cardiovascular Diseases. 2018 Jan 1
• 7 citations
  Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - "Real World" Experience.
  Mark B. Effron, C. Michael Gibson> ;Progress in Cardiovascular Diseases. 2018 Jan 1
• 12 citations
  Multivessel Versus Culprit Vessel-Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE-ACS Observationa...
  Homam Ibrahim, Praneet K. Sharma, David J. Cohen, Gregg C. Fonarow, Lisa A. Kaltenbach, Mark B. Effron, Marjorie Zettler, Eric D. Peterson, Tracy Y. Wang> ;Journal of the American Heart Association. 2017 Oct 5
• 35 citations
  Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coro...
  Usman Baber, Jaya Chandrasekhar, Samantha Sartori, Melissa Aquino, Annapoorna Kini, Samir R. Kapadia, William S. Weintraub, Joseph B. Muhlestein, Birgit Vogel, Michela...> ;JACC. Cardiovascular Interventions. 2017 Oct 23
• 46 citations
  Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction : A Secondary Analysis of the TRANSLATE-ACS Study.
  Patrícia O. Guimarães, Arun Krishnamoorthy, Lisa A. Kaltenbach, Kevin J. Anstrom, Mark B. Effron, Daniel B. Mark, Patrick L. McCollam, Linda Davidson-Ray, Eric D. Pete...> ;JAMA Cardiology. 2017 Jul 1
• 54 citations
  Sex-related Differences in Outcomes Among Men and Women Under 55 Years of Age With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results From ...
  Jaya Chandrasekhar, Usman Baber, Samantha Sartori, Michela Faggioni, Melissa Aquino, Annapoorna Kini, William S. Weintraub, Sunil V. Rao, Samir Kapadia, Sandra Weiss, ...> ;Catheterization and Cardiovascular Interventions. 2017 Mar 1
• 26 citations
  Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: ...
  Usman Baber, Samantha Sartori, Melissa Aquino, Annapoorna Kini, Samir R. Kapadia, Sandra Weiss, Craig Strauss, J. Brent Muhlestein, Catalin Toma, Sunil V. Rao, Anthony...> ;American Heart Journal. 2017 Jun 1
• 13 citations
  Association of measured platelet reactivity with changes in P2Y12 receptor inhibitor therapy and outcomes after myocardial infarction: Insights into routine clinical p...
  Akshay Bagai, Eric D. Peterson, Lisa A. McCoy, Mark B. Effron, Marjorie Zettler, Gregg W. Stone, Timothy D. Henry, David J. Cohen, Phillip J. Schulte, Kevin J. Anstrom...> ;American Heart Journal. 2017 May 1
• 52 citations
  Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the Treatment with Adenosine Diphosp...
  Marjorie Zettler, Eric D. Peterson, Lisa A. McCoy, Mark B. Effron, Kevin J. Anstrom, Timothy D. Henry, Brian A. Baker, John C. Messenger, David Cohen, Tracy Y. Wang> ;American Heart Journal. 2017 Jan 1
• TCT-111 Relationship between anemia, prasugrel use and clinical outcomes in contemporary percutaneous coronary intervention for acute coronary syndromes.
  Chandrasekhar J, Baber U, Sartori S, Aquino M, Faggioni M, Vogel B, Farhan S, Muhlestein JB, Henry T, Strauss C, Toma C, Weintraub W, Weiss S, DeFranco A, Kini A, Effr...> ;J. Am. Coll. Cardiol.. 2016-11-01
• Join now to see all

Journal Articles

• How reliable are patient-reported rehospitalizations? Implications for the design of future practical clinical studies  
  Krishnamoorthy A, Peterson ED, Knight JD, Anstrom KJ, Effron MB, Zettler ME, Davidson-Ray L, Baker BA, McCollam PL, Mark DB, Wang TY, J Am Heart Assoc, 1/1/2016
• Unplanned inpatient and observation rehospitalizations after acute myocardial infarction insights from the treatment with adenosine diphosphate receptor inhibitors: Lo...  
  Hess CN, Wang TY, McCoy LA, Messenger JC, Effron MB, Zettler ME, Henry TD, Peterson ED, Fonarow GC, Circulation, 1/1/2016
• Comparative resource utilization and costs for patients with acute coronary syndrome managed with percutaneous coronary intervention treated with clopidogrel or prasugrel  
  Bae JP, Faries DE, Ernst FR, Lipkin C, Zhao Z, Moretz C, Lieu HD, Effron MB, Am J Health-Syst Pharm, 1/1/2016
• Impact of bleeding on quality of life in patients on DAPT: Insights from TRANSLATE-ACS  
  Amin AP, Wang TY, McCoy L, Bach RG, Effron MB, Peterson ED, Cohen DJ, J Am Coll Cardiol, 1/1/2016
• Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from ...  
  Chandrasekhar J, Usman Baber U, Samantha Sartori S, Michela Faggioni M et al, Catheterization Cardiovasc Intv, 1/1/2016
• Predictors of 1 year net adverse cardiovascular events (NACE) among ACS patients undergoing PCI with clopidogrel or prasugrel: analysis from the PROMETHEUS registry  
  Wayangankar SA, Baber U, Poddar K, Weiss S, Henry T, Muhlestein J, Baker B, Mehran R, Kini A, Sartori S, Rao S, Weintraub W, Strauss C, DeFranco A, Toma C, Keller S, E..., J Am Coll Cardiol, 1/1/2016
• Use of clopidogrel versus prasugrel in patients undergoing percutaneous coronary intervention: factors influencing real-world therapeutic decision-making  
  Salianski O, Baber U, Sartori S, Aoi S, Aquino M, Chandrasekhar J, Kini A, Rao S, Weintraub W, Weiss S, Henry T, Kapadia S, Poddar K, DeFranco A, Muhlestein J, Toma C,..., J Am Coll Cardiol, 1/1/2016
• Incidence, predictors and impact of stroke after percutaneous coronary intervention for acute coronary syndromes: results from the PROMETHEUS registry  
  Giustino G, Baber U, Sartori S, Aoi S, Aquino M, Chandrasekhar J, Weintraub W, Rao S; Weiss S, Henry T, Kapadia S. Poddar K, DeFranco A, Muhlestein J, Toma C, Effron M..., J Am Coll Cardiol, 1/1/2016
• The association of discharge aspirin dose with outcomes after acute myocardial infarction: insights from the TRANSLATE-ACS study  
  Xian Y, Wang TY, McCoy LA, Effron MB, Henry TD, Bach RG, Zettler ME, Baker BA, Fonarow GC, Peterson ED, Circulation, 1/1/2015
• Early medication nonadherence after acute myocardial infarction: Insights into actionable opportunities from the TReatment with ADP receptor iNhibitorS: Longitudinal A...  
  Mathews R, Peterson ED, Honeycutt E, Chin CT, Effron MB, Zettler M, Fonarow GC, Henry TD, Wang TY, Circ Cardiovasc Qual Outcomes, 1/1/2015
• Cluster-randomized clinical trial examining the impact of platelet function testing on practice: The TReatment with Adenosine diphosphate receptor iNhibitorS: Longitud...  
  Wang TY, Henry TD, Effron MB, Honeycutt E, Hess CN, MD, Zettler ME, Cohen DJ, Baker BA, Berger PB, Anstrom KJ, Angiolillo DJ, Peterson ED, Circ Cardiovasc Interv, 1/1/2015
• Contemporary use of platelet function and pharmacogenomic testing among acute myocardial infarction patients undergoing percutaneous coronary intervention in the Unite...  
  Wang TY, Henry TD, McCoy LA, Berger PB, Cohen DJ, Effron MB, Zettler M, Baker BA, Messenger JC, Peterson ED, Am Heart J, 1/1/2015
• One-year post-discharge resource utilization and treatment patterns of patients with acute coronary syndrome managed with percutaneous coronary intervention and treate...  
  Simeone JC, Molife C, Marrett E, Frech-Tamas F, Effron MB, Nordstrom BL, Zhu E, Keller S, Murphy BR, Nair KV, Vetrovec G, Page RL, McCollam PL, Am J Cardiovasc Drugs, 1/1/2015
• Selection of prasugrel versus clopidogrel among myocardial infarction patients with high versus low predicted mortality and bleeding risks: Insights from TRANSLATE-ACS  
  Vora A, Peterson E, McCoy L, Effron M, Anstrom K, Faries D, Zettler M, Fonarow G, Baker B, Stone G, Wang T, J Am Coll Cardiol, 1/1/2015
• Impact of proton pump inhibitor use on the comparative safety and effectiveness of prasugrel versus clopidogrel: Insights from TRANSLATE-ACS  
  Jackson L, Peterson E, McCoy L, Ju C, Zettler M, Baker B, Messenger J, Faries D, Effron M, Cohen D, Wang T, J Am Coll Cardiol, 1/1/2015
• Outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention receiving an oral anticoagulant and dual antiplatelet therapy: a co...  
  Jackson II LR, Ju C, Zettler M, Messenger JC, Cohen DJ, Stone GW, Baker BA, Effron MB, Peterson ED, Wang TY, J Am Coll Cardiol Intv, 1/1/2015
• Clinical outcomes using prasugrel or ticagrelor based on physician treatment decisions in patients with acute coronary syndrome undergoing percutaneous coronary interv...  
  Effron MB, Nair KV, Molife C, Keller SY, Page RL, Simeone J, Murphy B, Nordstrom BL, McCollam PL, Vetrovec GW, J Am Coll Cardiol, 1/1/2015
• Impact of prasugrel versus clopidogrel in ACS patients undergoing PCI with short or long stents: Results from the PROMETHEUS Study  
  Chandrasekhar J, Baber U, Sartori S, Aquino M, Henry TD, Kini A, Kapadia S, Rao S, Weiss S, Muhlestein JB, Poddar KL, Baker BA, Keller SY, Effron MB, Chao J, Strauss C..., J Am Coll Cardiol, 1/1/2015
• Impact of prasugrel versus clopidogrel in smokers and non-smokers undergoing PCI for ACS: Results from the PROMETHEUS Study  
  Chandrasekhar J, Baber U, Sartori S, Aquino M, DeFranco A, Muhlestein JB, Weiss S, Henry TD, Effron MB, Strauss CE, Keller SY, Baker BA, Weintraub W, Chao J, Poddar KL..., J Am Coll Cardiol, 1/1/2015
• Effect of prasugrel versus clopidogrel in ACS patients with high or low BMI undergoing PCI: Results from the PROMETHEUS Study  
  Chandrasekhar J, Baber U, Sartori S, Aquino M, Strauss CE, Muhlestein JB, Weiss S, Effron MB, Keller SY, Baker BA, Chao J, Rao S, Kapadia S, Poddar KL, DeFranco A, Kin..., J Am Coll Cardiol, 1/1/2015
• Temporal associations between myocardial infarction, major bleeding and mortality risk in ACS patients undergoing PCI: Insights from the PROMETHEUS cohort  
  Baber U, Chao J, Chandrasekhar J, Sartori S, Aquino M, Kini A, Rao S, Weintraub W, Weiss S, Strauss C, Kapadia S, Henry T, DeFranco A, Muhlestein B, Toma C, Pocock S, ..., J Am Coll Cardiol, 1/1/2015
• Switching of ADP receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the TRANSLATE-ACS observational study  
  Zettler ME, Peterson ED, McCoy LA, Effron MB, Anstrom KJ, Henry TD, Baker BA, Messenger JC, Cohen DJ, Wang TY, Circulation, 1/1/2015
• ADP receptor inhibitor therapy use beyond 12 months in community practice: Results from the TRANSLATE-ACS registry  
  Hansen JD, McCoy LA, Cohen DJ, Henry TD, Gregg Fonarow GC, Effron MB, Zettler ME, Baker BA, Peterson ED, Wang TY, Circulation, 1/1/2015
• Switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights into...  
  Bagai A, Peterson ED, Honeycutt E, Effron MB, Cohen DJ, Goodman SG, Anstrom KJ, Gupta A, Messenger JC, Wang TY, Eur Heart J Acute Cardiovasc Care, 1/16/2014
• Pharmacodynamic Evaluation of switching from ticagrelor to prasugrel in subjects with stable coronary artery disease: Results of the SWAP-2 study  
  Angiolillo DJ, Curzen N, Gurbel P, Vaitkus P, Lipkin F, Li W, Jakubowski JA, Zettler M, Effron MB, and Trenk D, J Am Coll Cardiol, 1/1/2014
• Join now to see all

Books/Book Chapters

• Scientific American Medicine 
  Chapter: Circulatory shock 
  Page 1 - 11Effron MB, Chernow BEditors: Rubenstein E, Federman DD.1992

Abstracts/Posters

• Triple therapy after acute myocardial infarction: a comparison of clopidogrel vs. prasugrel from the TRANSLATE-ACS study.
  Jackson L, Zettler M, Peterson ED, Ju C, Effron MB, Messenger J, Cohen D, Stone G, Wang TY, J Am Coll Cardiol, 1/1/2014
• Efficacy and safety of pretreatment among contemporary acute myocardial infarction patients treated with percutaneous coronary intervention: insights from the TRANSLAT...
  Effron MB, Wang TY, Fonarow GC, Henry TD, Zettler M, Baker BA, McCoy LA, Peterson ED, J Am Coll Cardiol, 1/1/2014
• Early Cessation of ADP Receptor Inhibitors Among Acute Myocardial Infarction Patients Treated with PCI: Insights from the TRANSLATE-ACS Study.
  Fosbol EL, Peterson E, Honeycutt E, Zettler M, Messenger L, Waksman R, Effron M, Vaitkus P, Cohen D, Wang T, J Am Coll Cardiol, 1/1/2013
• The Association of Discharge Aspirin Dose and Outcomes in Acute Myocardial Infarction: Insights from the TRANSLATE-ACS Study.
  Xian Y, Wang T, Kaltenbach L, Effron M, Henry T, Bach R, Zettler M, Vaitkus P, Fonarow G, Peterson E, J Am Coll Cardiol, 1/1/2013
• Contemporary use of platelet function and pharmacogenomics testing among acute myocardial infarction patients treated with PCI in the United States: insights from the ...
  Wang TY, Henry TD, Mccoy LA , Berger PB, Cohen DJ, Effron MB, Zettler M, Vaitkus PT, Messenger JC, Peterson ED, Eur Heart J, 1/1/2013
• Comparative effectiveness of prasugrel vs. clopidogrel among acute myocardial infarction patients treated with percutaneous coronary intervention: 30-day outcomes from...
  Wang TY, Zettler M, Effron MB, McCoy L, Anstrom K, Fonarow GC, Messenger JC, Stone G, Cohen D, Henry TD, Peterson E, J Am Coll Cardiol, 1/1/2013
• High on-treatment platelet reactivity among contemporary acute myocardial infarction patients treated with percutaneous coronary intervention: Insights from the TRANSL...
  Bagai A, Peterson E, Honeycutt E, Effron MB, Stone G, Henry TD, Cohen D, Anstrom K, Wang TY, J Am Coll Cardiol, 1/1/2013
• A Pharmacodynamic evaluation of switching from ticagrelor to prasugrel in patients with stable coronary artery disease: Results of the SWAP-2 study.
  Angiolillo DJ, Curzen N, Gurbel PA, Vaitkus P, Lipkin F, Jakubowski JA, Zettler M, Effron MB, Trenk D, Circulation, 1/1/2013
• Medication nonadherence among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights from the TRANSLATE-ACS study.
  Mathews R, Peterson E, Honeycutt E, Chin CT, Ryan K, Effron M, Zettler M, Rozek M, Henry T, Wang T, J Am Coll Cardiol, 1/1/2012
• Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients: The TRIPLET trial.
  Diodati J, Fung A, Saucedo J, Mehta A, Oguzhan A, Gaxiola E, Sarmento-Leite R, Belardi J, French J, Cardillo T, Effron M, Fisher H, Angiolillo DJ, EuroIntervention, 1/1/2012
• Medication adherence and persistence of prasugrel initiators post ACS-PCI.
  Simeone JC, Nordstrom B, Zhao Z, Molife C, McCollam PL, Ye X, Effron MB, Value in Health, 1/1/2012
• Characteristics of patients treated with thienopyridines following ACS-PCI.
  Nordstrom B, Simeone JC, Zhao Z, Molife C, McCollam PL, Ye X, Effron MB, Value in Health, 1/1/2012
• Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients: high on-treatment platelet reactivity analysis of the TRIPLET...
  Diodati J, Angiolillo D, Saucedo J, Cardillo T, Jakubowski J, Henneges C, Effron M, Lipkin F, Fisher H, J Am Coll Cardiol, 1/1/2012
• Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients: The TRIPLET trial.
  Diodati JG, Fung A, Saucedo JF, Oguzhan A, Gaxiola E, Cardillo TE, Effron MB, Fisher HN, Henneges C, Angiolillo DJ, Can J Cardiol, 1/1/2012
• Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways.
  Braun OO, Angiolillo DJ, Ferreiro JL, Jakubowski JA, Winters KL, Effron MB, Duvvuru S, Costigan TM, Sundseth S, Walker JR, Jorge F Saucedo JF, Neal S Kleiman NS, David..., Circulation, 1/1/2012
• Unplanned 30-Day Readmission Risk Among Patients with Acute Myocardial Infarction: A Report from TRANSLATE-ACS.
  Hess CN, Wang TY, Kaltenbach L, Emily Honeycutt E, Messenger JC, Smith WT, Zettler ME, Effron MB, Henry TD, Peterson ED, Fonarow GC, Circulation, 1/1/2012
• In-hospital switching of ADP receptor inhibitors in myocardial infarction patients treated with percutaneous coronary intervention: insights from the TRANSLATE-ACS study.
  Bagai A, Peterson ED, Honeycutt E, Effron MB, Cohen DJ, Goodman SG, Anstrom K, Anjan Gupta A, Messenger JC, Wang TY, Circulation, 1/1/2012
• Post-discharge bleeding and thienopyridine discontinuation among AMI patients treated with PCI: insights from the TRANSLATE-ACS study.
  Wang TY, Honeycutt E, Henry TD, Effron MB, Messenger JC, Cohen DJ, Mark DB, Stone GW, Singh M, Rozek M, Fonarow GC, Peterson ED, J Am Coll Cardiol, 1/1/2011
• Lack of rebound in platelet reactivity following cessation of prasugrel or clopidogrel in type 2 diabetes mellitus patients with coronary artery disease: insights from...
  Angiolillo DJ, Jakubowski JA, Frelinger AL, Zafar MU, Saucedo JF, Michelson AD, Zhu B, Ojeh CK, Baker BA, Effron MB, Eur Heart J, 1/1/2010
• Prasugrel and clopidogrel persistence and discontinuation among lower bleeding risk patients undergoing percutaneous coronary intervention for acute coronary syndromes.
  Zhu B, McCollam PL, Bae JP, Ramaswamy K, Johnston JA, Effron MB, Value in Health, 1/1/2009
• Reduction in rehospitalizations and associated costs within 30 days after discharge from hospitalization for acute coronary syndromes and planned PCI with prasugrel vs...
  Mahoney EM, Wang K, Bae JP, Zhu B, Marciniak MD, Effron MB, Cohen DJ, Value in Health, 1/1/2009
• Comparison of prasugel with clopidogrel on platelet function in coronary artery disease patients with type 2 diabetes mellitus - Third Optimizing Anti-Platelet Therapy...
  Angiolillo DJ, Badimon J, Saucedo JF, Frelinger AL, Michelson AD, Jakubowski JA, Zhu B, Ojeh CK, Baker B, Effron MB, Circulation, 1/1/2009
• Decrease in poor responders on switching from clopidogrel to prasugrel: Results from the SWitching Anti Platelet (SWAP) study.
  Saucedo JF, Angiolillo DJ, DeRaad R, Frelinger AL, Gurbel PA, Costigan TM, Jakubowski JA, Ojeh CK, Effron MB, SWAP Investigators, Circulation, 1/1/2009
• One-year follow-up results of the FINESSE trial of facilitated PCI.
  Ellis SG, Tendera M, De Belder MA, van Boven AJ, Widimsky P, Janssens L, Andersen HR, Betriu A, Savonitto S, Adamus J, Peruga JZ, Kosmider M, Katz O et al, J Am Coll Cardiol, 1/1/2008
• Benefit of facilitated PCI in high risk ST elevation MI patients presenting to non-PCI hospitals.
  Herrmann HC Lu J, Brodie BR, Armstrong PW, Montalescot G, Betriu A, Neumann F-J, Effron MB, Barnathan ES, Topol EJ, Ellis SG, Am J Cardiol, 1/1/2008
• Join now to see all

Lectures

• Optimal Duration of P2Y12 Inhibitor Therapy After Stenting: Is There A Clear Answer? 
  Medical College of Virginia, Richmond, VA, 2014; New Orleans, LA, 2015 - 1/18/2015
• Antithrombotic Therapy in the Treatment of Acute Coronary Syndrome 
  Charleston, WV - 1/17/2014
• Safe PCI for Women: View from the Pharmaceutical Industry 
  White Oak, MD - 1/29/2013
• Drug and device safety: Can we work from common ground? 
  White Oak, MD - 1/4/2012
• Intracranial, GI, & surgical bleeding with more potent agents: A view from industry 
  White Oak, MD - 1/7/2011
• Bleeding, procedural outcomes and other key endpoints/variables - A drug industry view 
  White Oak, MD - 1/23/2010
• Antiplatelet therapy: a paradigm for personalized medicine 
  Krannert Institute of Cardiology, Indiana University School of Medicine - 1/8/2010
• Prasugrel Overview 
  Snowmass, CO - 1/8/2009
• Full disclosure: Trial Registries and Its Effect on Phase IV Studies 
  Philadelphia, PA - 1/19/2005
• Reperfusion Therapy in ST Eleavation Myocardial Infarction (STEMI) - Fibrinolysis, Facilitated PCI, or PCI with Adjunctive Therapy? 
  University of Massachusetts Medical Center, Worcester, MA - 1/5/2005
• The New ACC/AHA STEMI Guidelines - Role of Adjunctive Pharmacotherapeutics for Primary Percutaneous Intervention (PCI) 
  St Vincent Hospital, Worcester, MA - 1/20/2004
• Drotrecogin alfa (activated) in the Treatment of Severe Sepsis 
  Westchester Medical Center, Valhalla, NY - 1/19/2004
• Recent Advances in Therapy Using Glycoprotein IIb/IIIa Receptor Inhibitors 
  Albert Einstein Medical Center, Philadelphia, PA - 1/3/2000
• New Pharmacological Approaches Adjunctive to Interventional Coronary Procedures 
  Jerusalem, Israel - 1/30/1999
• Insights into Abciximab: The Lilly/Centocor Experience 
  Washington, DC - 1/22/1999
• Efficacy and Cost Effectiveness of GP IIb/IIIa Inhibitors 
  Multiple Locations, 1999 - 1/2/1999
• Cost Effectiveness of GP IIb/IIIa Inhibitors 
  Jerusalem, Israel - 1/1/1999
• The CADILLAC Trial; Preliminary Results 
  Jerusalem, Israel - 1/1/1999
• Abciximab Update 
  Latter Day Saints Hospital, Salt Lake City, UT - 1/21/1998
• Use of Platelet Glycoprotein IIb/IIIa Inhibitors in the Treatment of Coronary Artery Disease 
  Tallahassee Memorial Regional Medical Center, Tallahassee, FL, 1997; West Virginia University School - 1/15/1998
• IIb/IIIa receptor inhibitors 
  West Pennsylvania Hospital, Pittsburgh, PA - 1/29/1997
• Antiplatelet therapy in acute coronary syndromes 
  Lankenau Hospital, Wynnewood, PA, 1997; Sinai Hospital of Baltimore, Baltimore, MD, 1997 - 1/13/1997
• Abciximab, a new potent antiplatelet agent 
  Multiple Locations, 1997 - 1/6/1997
• Recent trends in inotrope therapy 
  Madras, India - 1/6/1997
• Use of c7E3 in coronary angioplasty 
  Multiple Locations, 1996 - 1/24/1996
• Join now to see all

Other

• Preventive Cardiology 
  Effron MB
  Northern High School, Baltimore, MD - 1/14/1991
• Clot dissolving drugs 
  Effron MB, "The Heart of the Matter" Radio Program, Series 210A, National Emergency Medicine Association
  1/1/1990